Overview
Monoclonal antibodies (mAbs) are a type of engineered antibody produced from a single B-cell clone, which can be used to target and bind to a particular antigen. This makes them useful research tools as well as treatments for a variety of medical conditions in humans and animals, such as cancer, autoimmune diseases and inflammation. They have shown potential for clinical use in targeted therapy, diagnostics, preventive medicine and regenerative medicine. mAbs are also used in research to analyse the structure and function of proteins, investigate signalling pathways and monitor metabolic pathways.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
How this research is being cited
The 12 articles above have been cited 53 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2026 · BMC Bioinformatics
-
2024 · Experimental Dermatology
-
2024 · Experimental Dermatology
-
2024 · WIREs Mechanisms of Disease
-
2023 · Biosensors and Bioelectronics
-
2023 · International Immunopharmacology
-
2023 · WIREs Mechanisms of Disease
-
2023 · International Journal of Pharmaceutical Sciences Review and Research
A sample of recent works citing this journal's research on Monoclonal Antibody, linking to each citing work.